This episode confronts a sobering reality: neonates are often an afterthought in drug development. Join leading experts Mary Short, Dr. Wakako Eklund, and Dr. Kanwaljit Singh as they shine a light on the critical gaps in neonatal drug research and what it means for nurses and APRNs at the bedside.
You will learn why most medications used in the NICU are not specifically designed for newborns, how off-label use puts our most vulnerable patients at risk, and why FDA-approved, age-appropriate formulations are essential for safe and effective care.
Note that free CEU is available through NANN’s iLearn platform: “Bridging the Gap: Empowering Neonatal Nurses in Drug Development for Neonates.”